- Home
- UPXI vs COEP Comparison
UPXI vs COEP Comparison
Compare UPXI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPXI | COEP |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.3M | 91.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | UPXI | COEP |
|---|---|---|
| Price | $0.90 | $16.40 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 92.3K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,811,345.00 | N/A |
| Revenue This Year | $118.99 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $6.80 |
| 52 Week High | $12.35 | $21.41 |
Technical Indicators
Market Signals| Indicator | UPXI | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 31.18 | 72.18 |
| Support Level | $0.54 | $13.77 |
| Resistance Level | $1.17 | $19.19 |
| Average True Range (ATR) | 0.08 | 1.15 |
| MACD | -0.04 | 0.47 |
| Stochastic Oscillator | 9.36 | 87.62 |
Price Performance
Historical ComparisonAbout UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.